Table 3

Changes from baseline in trough FEV1 and ACQ-7 average score by visit, and asthma symptoms summarised throughout the treatment period

QMF149MFTreatment difference: QMF149–MF
Variablen (%)LS meanSEn (%)LS meanSELS meanSE95% CI
Change from baseline in trough FEV1 by visit (L)
 Overall727 (100)0.070.023746 (100)−0.050.0230.12***0.014(0.09 to 0.15)
 Week 4709 (97.5)0.090.023728 (97.6)−0.040.0230.13***0.014(0.10 to 0.16)
 Week 12681 (93.7)0.080.024693 (92.9)−0.020.0240.11***0.016(0.08 to 0.14)
 Week 26643 (88.4)0.080.024658 (88.2)−0.040.0240.12***0.017(0.08 to 0.15)
 Week 52431 (59.3)0.070.025443 (59.4)−0.070.0250.14***0.018(0.11 to 0.18)
 Week 68176 (24.2)0.060.028171 (22.9)−0.050.0280.10***0.026(0.05 to 0.15)
 Final visit674 (92.7)0.060.025699 (93.7)−0.070.0240.12***0.018(0.09 to 0.16)
Change from baseline in ACQ-7 score by visit
 Overall728 (100)−0.490.049745 (100)−0.290.049−0.19***0.028(−0.25 to −0.14)
 Week 4709 (97.4)−0.350.049734 (98.5)−0.150.049−0.20***0.031(−0.26 to −0.14)
 Week 12679 (93.3)−0.450.050697 (93.6)−0.240.050−0.21***0.034(−0.28 to −0.15)
 Week 26648 (89.0)−0.500.051660 (88.6)−0.380.051−0.13***0.035(−0.20 to −0.06)
 Week 52432 (59.3)−0.520.052447 (60.0)−0.350.052−0.17***0.038(−0.24 to −0.10)
 Week 68178 (24.5)−0.550.056173 (23.2)−0.320.057−0.23***0.050(−0.33 to −0.13)
 Final visit675 (92.7)−0.550.052687 (92.2)−0.320.052−0.22***0.040(−0.30 to −0.14)
Percentage of days with no asthma symptoms during
 Morning73022.32.1774618.42.173.9***1.20(1.5 to 6.3)
 Daytime73127.12.9674919.52.957.7***1.63(4.5 to 10.9)
 Night-time73023.62.6974617.32.686.3***1.49(3.4 to 9.2)
  • ***p≤0.001. The ACQ-7 score ranges from 0=good control of asthma to 6=very poor control of asthma.

  • ACQ-7, Asthma Control Questionnaire; FEV1, forced expiratory volume in 1 s; LS, least squares; MF, mometasone furoate; SE, standard error.